Cargando…
Real-World Evidence for Oritavancin Use in Gram-Positive Infections
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7334308/ https://www.ncbi.nlm.nih.gov/pubmed/32613318 http://dx.doi.org/10.1007/s40801-020-00197-5 |
| _version_ | 1783553913168855040 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7334308 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Springer International Publishing |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-73343082020-07-09 Real-World Evidence for Oritavancin Use in Gram-Positive Infections Drugs Real World Outcomes Announcement Springer International Publishing 2020-07-01 /pmc/articles/PMC7334308/ /pubmed/32613318 http://dx.doi.org/10.1007/s40801-020-00197-5 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/. |
| spellingShingle | Announcement Real-World Evidence for Oritavancin Use in Gram-Positive Infections |
| title | Real-World Evidence for Oritavancin Use in Gram-Positive Infections |
| title_full | Real-World Evidence for Oritavancin Use in Gram-Positive Infections |
| title_fullStr | Real-World Evidence for Oritavancin Use in Gram-Positive Infections |
| title_full_unstemmed | Real-World Evidence for Oritavancin Use in Gram-Positive Infections |
| title_short | Real-World Evidence for Oritavancin Use in Gram-Positive Infections |
| title_sort | real-world evidence for oritavancin use in gram-positive infections |
| topic | Announcement |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7334308/ https://www.ncbi.nlm.nih.gov/pubmed/32613318 http://dx.doi.org/10.1007/s40801-020-00197-5 |